Drug Target Review – Issue 1 2019
In this issue: AI-driven automated chemistry as a tool to accelerate drug discovery processes, the shifting landscape of immuno-oncology, and how lipid molecules provide an insight into biological research.
List view / Grid view
In this issue: AI-driven automated chemistry as a tool to accelerate drug discovery processes, the shifting landscape of immuno-oncology, and how lipid molecules provide an insight into biological research.
A DNA vaccine developed through the use of unique tumour antigens could lead the way towards vaccinating people against cancer...
Innovative new technology will use electron beams to produce inactivated vaccines quickly, reproducibly and without the use of chemicals...
Researchers have developed a vaccine to combat the opioid epidemic and to prevent deaths, with possible applications of the vaccine in many areas...
Researchers have developed a comprehensive way to evaluate how immune responses of humanised mice measure up to actual humans...
Researchers have developed a polio vaccine that doesn't require refrigeration, meaning it could someday be used all over the world...
A team of scientists have developed the first modelling system for testing age-specific human immune responses to vaccines -- outside the body...
Study confirms biological mechanism responsible for latent HIV reservoirs; suggests strategies for a functional HIV cure...
An experimental cancer vaccine that boosts the immune system's ability to fight cancers could work in tandem with other cancer therapies to fight aggressive tumours, scientists have reported...
Researchers developed a novel DNA influenza vaccine based on four micro-consensus antigenic regions selected to represent the diversity of seasonal H3N2 viruses...
A Lassa fever vaccine offers researchers a different way to test for protection, which could aid the development of more potent vaccines...
Researchers at The Wistar Institute have developed a DNA based vaccine that has offered compete protection against the Ebola virus in preclinical trials...
Researchers have developed PeptiENV, a cancer vaccine platform, which can be used to improve the therapeutic efficacy of oncolytic enveloped viruses...
DNA vaccine optimised to cross-react with several MAGE-A isoforms generates a robust immune response and antitumour activity in a pre-clinical model of melanoma...
Using sugar molecules researchers have developed a new vaccine for hay fever that may reduce treatment times and increase the effectiveness of treatments...